Sema4

company

About

Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

  • 501 - 1000

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$200M
Industries
Artificial Intelligence,Health Care,Health Diagnostics,Machine Learning,Medical,Predictive Analytics
Founded date
Jan 1, 2017
Number Of Employee
501 - 1000
Operating Status
Active

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$441M
Sema4 has raised a total of $441M in funding over 2 rounds. Their latest funding was raised on Jan 18, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 18, 2022 Post-IPO Equity $200M 1 Detail
Jul 29, 2020 Series C $121M 1 Detail
Aug 30, 2019 Series B $120M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Sema4 is funded by 2 investors. Pfizer and Oak HC/FT are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Post-IPO Equity
Oak HC/FT Series C